NEOGENOMICS INC (NEO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 300M 600M 900M Q2 '21: 488.7M Q3 '21: 484.6M Q4 '21: 484.3M Q1 '22: 486M Q2 '22: 489.3M Q3 '22: 496.8M Q4 '22: 509.7M Q1 '23: 529.8M Q2 '23: 551.6M Q3 '23: 574.8M Q4 '23: 591.6M Q1 '24: 610.7M Q2 '24: 628.2M Q3 '24: 644.1M Q4 '24: 660.6M Q1 '25: 672.4M Q2 '25: 689.2M Q3 '25: 709.2M Q4 '25: 727.3M Q1 '26: 746M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit TTM

0 150M 300M 450M Q2 '21: 206.1M Q3 '21: 199.3M Q4 '21: 187.1M Q1 '22: 183.7M Q2 '22: 174.7M Q3 '22: 176.3M Q4 '22: 187.9M Q1 '23: 204.5M Q2 '23: 220.4M Q3 '23: 233.8M Q4 '23: 244.6M Q1 '24: 255.3M Q2 '24: 267.9M Q3 '24: 280.4M Q4 '24: 290.1M Q1 '25: 297.9M Q2 '25: 302.6M Q3 '25: 308.2M Q4 '25: 314.3M Q1 '26: 321.9M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Income TTM

-180M -120M -60M 0 60M 120M 180M Q2 '21: -27.3M Q3 '21: -71.6M Q4 '21: -118.8M Q1 '22: -155.7M Q2 '22: -173M Q3 '22: -172.8M Q4 '22: -157.6M Q1 '23: -140.7M Q2 '23: -130.9M Q3 '23: -115.5M Q4 '23: -107.7M Q1 '24: -103.2M Q2 '24: -95.3M Q3 '24: -92.3M Q4 '24: -92.1M Q1 '25: -89.4M Q2 '25: -115.1M Q3 '25: -120.9M Q4 '25: -115.9M Q1 '26: -106.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income TTM

-180M -120M -60M 0 60M 120M 180M Q2 '21: 71.7M Q3 '21: 48.8M Q4 '21: -8.3M Q1 '22: -35.6M Q2 '22: -146.8M Q3 '22: -163.3M Q4 '22: -144.2M Q1 '23: -125.6M Q2 '23: -114.7M Q3 '23: -96.3M Q4 '23: -88M Q1 '24: -84.2M Q2 '24: -78.5M Q3 '24: -77.7M Q4 '24: -78.7M Q1 '25: -77.6M Q2 '25: -104M Q3 '25: -113.5M Q4 '25: -108M Q1 '26: -99.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue TTM

0 150M 300M 450M Q2 '21: 282.6M Q3 '21: 285.3M Q4 '21: 297.3M Q1 '22: 302.2M Q2 '22: 314.6M Q3 '22: 320.4M Q4 '22: 321.8M Q1 '23: 325.3M Q2 '23: 331.2M Q3 '23: 341M Q4 '23: 347M Q1 '24: 355.4M Q2 '24: 360.4M Q3 '24: 363.7M Q4 '24: 370.5M Q1 '25: 374.5M Q2 '25: 386.5M Q3 '25: 401M Q4 '25: 413M Q1 '26: 424.1M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q2 '21: 7.3M Q3 '21: -962K Q4 '21: -26.7M Q1 '22: -58M Q2 '22: -73.6M Q3 '22: -82.1M Q4 '22: -66M Q1 '23: -49.6M Q2 '23: -34.2M Q3 '23: -23.4M Q4 '23: -2M Q1 '24: -15.2M Q2 '24: 264K Q3 '24: 15M Q4 '24: 7M Q1 '25: 7.6M Q2 '25: 14M Q3 '25: 13.7M Q4 '25: 5.2M Q1 '26: 22.4M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q2 '21: -49.2M Q3 '21: -64.6M Q4 '21: -90.9M Q1 '22: -114.5M Q2 '22: -119.1M Q3 '22: -120.4M Q4 '22: -96.9M Q1 '23: -82.2M Q2 '23: -64M Q3 '23: -49.7M Q4 '23: -30.7M Q1 '24: -39.6M Q2 '24: -29.7M Q3 '24: -21.5M Q4 '24: -34M Q1 '25: -32.4M Q2 '25: -19.2M Q3 '25: -17M Q4 '25: -21.8M Q1 '26: -5.1M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q4 '19: 107.8M Q1 '20: 104.5M Q2 '20: 107.9M Q3 '20: 119.2M Q1 '21: 116.2M Q2 '21: 131.2M Q3 '21: 122.6M Q1 '22: 123.6M Q2 '22: 124.1M Q3 '22: 124.4M Q1 '23: 125M Q2 '23: 125.4M Q3 '23: 125.7M Q1 '24: 126.1M Q2 '24: 126.4M Q3 '24: 127M Q1 '25: 127.4M Q2 '25: 127.9M Q3 '25: 128.4M Q1 '26: 129.2M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.11 -0.07 -0.04 0.00 0.04 0.07 0.11 Q4 '10: -0.09 Q1 '11: -0.09 Q2 '11: -0.07 Q3 '11: -0.04 Q4 '11: -0.03 Q2 '13: -0.01 Q3 '13: 0.03 Q4 '13: 0.05 Q1 '14: 0.05 Q2 '14: 0.05 Q3 '14: 0.02 Q4 '14: 0.02 Q1 '15: 0.01 Q2 '15: 0.00 Q3 '15: 0.01 Q4 '15: -0.04 Q1 '11 Q3 '11 Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q2 '15 Q4 '15

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.